Lin BioScience, Inc. engages in the development of drugs. It offers medicines for acute leukemia, solid tumors, type 2 diabetes, glioblastoma, and stargardt disease. The company was founded by Yue Hsin Lin on May 12, 2016 and is headquartered in Taipei, Taiwan.